Xuan Zhou

6PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersMolecular targetsNeural engineeringHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 04, 2026
CAF-derived PAI-1 serves as an EGFR ligand and fuels KRAS-mutant pancreatic cancer.

|Apr 27, 2026
Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer.

|Jul 10, 2023
Lysine methylation promotes NFAT5 activation and determines temozolomide efficacy in glioblastoma.

Yatian Li, Zhenyue Gao, Yuhong Wang

|Dec 31, 2022
Novel Insights of Anti-EGFR Therapy in HNSCC: Combined with Immunotherapy or Not?

Lin Dong, Yu Wang, Xiaofeng Yao

|Dec 15, 2022
Evolving landscape of PD-L2: bring new light to checkpoint immunotherapy.

Yuqing Wang, Jiang Du, Zhenyue Gao

|Oct 26, 2021
PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy.

Yiqi Xu, Zhenyue Gao, Ruxin Hu

Pageof 1

Frequent Collaborators

3 joint publications

Yu Ren

2 joint publications

Min Li

1 joint publications

Yongzhi Wang

1 joint publications

Xiuchao Wang